Novavax.
company in Gaithersburg, Maryland
- Reports this week
- 0
- Active events
- 0
- Connections
- 59
What's happening
Earlier this month
One to three months ago
-
On August 28, 2026, the FDA approved Moderna's mNEXSPIKE vaccine and gave the green light to Novavax's Nuvaxovid vaccine. Separately, ProFound Therapeutics was formed by Flagship Pioneering.Some support1 report
-
Novavax, Nvidia, Biogen, and Amgen are involved in developments regarding specialized infrastructure and their shared status as peers in the therapeutics segment.Some support2 reports
-
Taiwan is utilizing Moderna and Novavax doses for COVID-19 vaccination.Some support1 report
-
Novavax is involved in managing specific vaccine stock for high-risk groups under the oversight of a governmental public health body.Some support2 reports
Gone quiet
No new reports in 90+ days-
Market performance comparison in the vaccine sector was noted, alongside an upcoming August 5th FDA decision on a flu candidate.Some support1 report
-
Young's career timeline includes appointments at TechImmune, service on the Novavax board, and academic/professional ties to GlaxoSmithKline in NYC and Houston.Some support1 report
-
AI stocks benefit from Trump-era tariffs, while Novavax released data showing its flu vaccine outperformed FLUZONE-HD.Some support2 reports
-
Novavax and Canopy Growth are facing lagging stock performance while operating in Canada and Germany.Some support1 report
-
Novavax is a vaccine maker operating in the medical sector.Some support1 report
-
Novavax's stock performance on July 31, 2025, was noted against the backdrop of the broader market's losses, showing both lags and outperformance.Some support3 reports
-
FDA approved Novavax's Nuvaxovid BLA, leading to Sanofi receiving a milestone payment and taking over U.S. commercial leadership.Well supported9 reports1 development inside
-
Novavax and Sanofi announced a partnership to facilitate vaccine access.Well supported3 reports
-
Incepta Pharmaceuticals and Novavax were mentioned in a report on August 13, 2025, noting that industry performance influences stock trends.Some support1 report
-
Novavax faces an uncertain outlook regarding its vaccine programs, as reported by Bank of America.Some support1 report
-
FDA approved updated COVID-19 vaccines on August 29, 2025, involving companies like Novavax, Moderna, and Pfizer.Well supported6 reports1 development inside
-
Novavax started using LinkedIn on September 3, 2025, for company information.Some support2 reports
-
Novavax received a milestone payment following regulatory approval in Japan.Some support1 report
-
Jefferies reaffirmed a buy rating on Novavax shares, amidst discussions regarding potential updates to COVID-19 vaccines and FDA considerations.Some support4 reports
-
Novavax stock is trading on the Nasdaq electronic stock exchange, with company news and ratings being aggregated by MarketBeat.Some support6 reports
No events began in the chosen period. Widen it, or reset.
Around Novavax this week
News at the entities that move Novavax most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Novavax
-
Food and Drug Administration StructuralIn 2007, CBS broadcast featured Andrews, Cordes, and Couric criticizing the Food and Drug Administration's problems.Moves Novavax
-
Jefferies Financial Group Mentioned togetherApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Novavax
-
Takeda StructuralTakeda is conducting Phase 3 studies in Japan.Moves Novavax
-
Sanofi OperationalSanofi and the Association of Science and Technology Centers announced a partnership focused on environmental education.Moves Novavax
-
Moderna OperationalAnalyst downgrades and market challenges are impacting Moderna amid waning demand for COVID-19 vaccines, alongside pipeline successes.Moves Novavax
Connections
The 19 strongest of 59, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Moderna Operational
Novavax and Moderna are direct competitors in the vaccine market, vying for market share and facing shared regulatory scrutiny.
-
Sanofi Structural
Novavax licensed its vaccine technology to Sanofi, which subsequently took over commercialization efforts and provided milestone payments.
-
FDA Structural
The FDA formally evaluates, regulates, and grants market approval for Novavax's vaccine products.
-
Pfizer Operational
Novavax and Pfizer are direct competitors offering alternative products in the market.
-
Takeda Structural
Takeda provides financial support to Novavax through royalty payments, boosting its market outlook.
-
Nasdaq Structural
Novavax is a publicly traded company that lists its shares and reports earnings on the Nasdaq stock exchange.
-
Sanofi Operational
An active commercial partnership exists where Sanofi's operations and revenue streams support Novavax's market momentum and product commercialization.
-
Food and Drug Administration Structural
The FDA regulates Novavax, granting market access through approvals and imposing delays.
Show all 19 connections
-
Biogen Operational
The evidence indicates that both companies are direct competitors operating as peers within the therapeutics segment.
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group provides financial ratings and research notes on Novavax.
-
Centers for Disease Control Operational
Novavax utilizes vaccine stock managed by the Centers for Disease Control for high-risk groups.
-
AstraZeneca Operational
Both Novavax and AstraZeneca are actively pursuing vaccine technology transfer.
-
MarketBeat Mentioned together
MarketBeat aggregates and reports financial data, news, and stock ratings for Novavax.
-
LinkedIn Operational
Novavax actively uses LinkedIn as a platform to gather company and general information.
-
TD Cowen Mentioned together
A is a financial services firm whose business includes providing market analysis and ratings for companies like B.
-
Incepta Pharmaceuticals Mentioned together
Both Incepta Pharmaceuticals and Novavax are categorized within the medical sector.
-
Nvidia Shared context
The two companies operate within the same high-tech ecosystem, where Nvidia's products require specialized infrastructure.
-
Gaithersburg Shared context
Novavax is based in Gaithersburg, Maryland.
-
Amgen Operational
Novavax and Amgen are identified as competitors operating within the therapeutics segment.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
2 events- On August 28, 2026, the FDA approved Moderna's mNEXSPIKE vaccine and gave the green light to Novavax's Nuvaxovid vaccine. Separately, ProFound Therapeutics was formed by Flagship Pioneering.
- Novavax, Nvidia, Biogen, and Amgen are involved in developments regarding specialized infrastructure and their shared status as peers in the therapeutics segment.
July 2026
2 eventsShow 1 earlier month
June 2026
15 events- Market performance comparison in the vaccine sector was noted, alongside an upcoming August 5th FDA decision on a flu candidate.
- Young's career timeline includes appointments at TechImmune, service on the Novavax board, and academic/professional ties to GlaxoSmithKline in NYC and Houston.
- AI stocks benefit from Trump-era tariffs, while Novavax released data showing its flu vaccine outperformed FLUZONE-HD.
- Novavax and Canopy Growth are facing lagging stock performance while operating in Canada and Germany.
- Novavax is a vaccine maker operating in the medical sector.
- Novavax's stock performance on July 31, 2025, was noted against the backdrop of the broader market's losses, showing both lags and outperformance.
- FDA approved Novavax's Nuvaxovid BLA, leading to Sanofi receiving a milestone payment and taking over U.S. commercial leadership.
- Novavax and Sanofi announced a partnership to facilitate vaccine access.
- Incepta Pharmaceuticals and Novavax were mentioned in a report on August 13, 2025, noting that industry performance influences stock trends.
- Novavax faces an uncertain outlook regarding its vaccine programs, as reported by Bank of America.
- FDA approved updated COVID-19 vaccines on August 29, 2025, involving companies like Novavax, Moderna, and Pfizer.
- Novavax started using LinkedIn on September 3, 2025, for company information.
- Novavax received a milestone payment following regulatory approval in Japan.
- Jefferies reaffirmed a buy rating on Novavax shares, amidst discussions regarding potential updates to COVID-19 vaccines and FDA considerations.
- Novavax stock is trading on the Nasdaq electronic stock exchange, with company news and ratings being aggregated by MarketBeat.